Abstract
Synthesis of thirteen new analogues of arginine vasopressin (AVP) has been described. Amino acid residues at positions 2 and 3 of AVP, [3-mercaptopropionic acid (Mpa)1]AVP (dAVP), [Mpa1,D-Arg8]VP (dDAVP) and [Mpa1,Val4,D-Arg8]VP (dVDAVP) were replaced with one amino acid residue using sterically constrained nonproteinogenic amino acids, 4-aminobenzoic acid (Abz), cis-4-aminocyclohexanecarboxylic acid (ach) or its trans-isomer (Ach). In the case of a potent V1a antagonist, [1-mercaptocyclohexaneacetic acid (Cpa)1]AVP, only one similar analogue has been prepared by replacing positions 2 and 3 with Abz. Unfortunately, all new peptides were inactive in bioassays for the pressor, antidiuretic and uterotonic in vitro activities in the rat.
Keywords: Analogues of arginine vasopressin (AVP), 4-aminobenzoic acid (Abz), cis-4-aminocyclohexanecarboxylic acid(ach), trans-4-aminocyclohexanecarboxylic acid (Ach), biological activity
Protein & Peptide Letters
Title: Influence of Conformationally Constrained Amino Acids Replacing Positions 2 and 3 of Arginine Vasopressin (AVP) and Its Analogues on Their Pharmacological Properties
Volume: 14 Issue: 3
Author(s): Dariusz Sobolewski, Adam Prahl, Izabela Derdowska, Anna Kwiatkowska, Jirina Slaninova and Bernard Lammek
Affiliation:
Keywords: Analogues of arginine vasopressin (AVP), 4-aminobenzoic acid (Abz), cis-4-aminocyclohexanecarboxylic acid(ach), trans-4-aminocyclohexanecarboxylic acid (Ach), biological activity
Abstract: Synthesis of thirteen new analogues of arginine vasopressin (AVP) has been described. Amino acid residues at positions 2 and 3 of AVP, [3-mercaptopropionic acid (Mpa)1]AVP (dAVP), [Mpa1,D-Arg8]VP (dDAVP) and [Mpa1,Val4,D-Arg8]VP (dVDAVP) were replaced with one amino acid residue using sterically constrained nonproteinogenic amino acids, 4-aminobenzoic acid (Abz), cis-4-aminocyclohexanecarboxylic acid (ach) or its trans-isomer (Ach). In the case of a potent V1a antagonist, [1-mercaptocyclohexaneacetic acid (Cpa)1]AVP, only one similar analogue has been prepared by replacing positions 2 and 3 with Abz. Unfortunately, all new peptides were inactive in bioassays for the pressor, antidiuretic and uterotonic in vitro activities in the rat.
Export Options
About this article
Cite this article as:
Sobolewski Dariusz, Prahl Adam, Derdowska Izabela, Kwiatkowska Anna, Slaninova Jirina and Lammek Bernard, Influence of Conformationally Constrained Amino Acids Replacing Positions 2 and 3 of Arginine Vasopressin (AVP) and Its Analogues on Their Pharmacological Properties, Protein & Peptide Letters 2007; 14 (3) . https://dx.doi.org/10.2174/092986607780090810
DOI https://dx.doi.org/10.2174/092986607780090810 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Therapy for Neurological Disorders: Challenges and Future Prospects for the Use of Growth Factors for the Treatment of Parkinsons Disease
Current Gene Therapy Circulating Biomarkers for the Diagnosis and Prognosis of Heart Failure
Current Medicinal Chemistry Nitric Oxide Signaling and the Cross Talk with Prostanoids Pathways in Vascular System
Medicinal Chemistry Quantifying Glomerular Filtration Rates: Kidney Function Analysis Method and Apparatus
Recent Patents on Biomarkers Diterpenes: A Therapeutic Promise for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Recent Advancements in Soft Tissue Regeneration
Recent Patents on Biomedical Engineering (Discontinued) Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology Value of Carnitine Therapy in Kidney Dialysis Patients and Effects on Cardiac Function from Human and Animal Studies
Current Drug Targets Actions of Relaxin on Non-Reproductive Tissues
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents PET Tracers for Mapping Adenosine Receptors as Probes for Diagnosis of CNS Disorders
Central Nervous System Agents in Medicinal Chemistry Epigenetics: New Concepts of Old Phenomena in Vascular Physiology
Current Vascular Pharmacology Programmed Cell Death Mechanisms in Neurological Disease
Current Molecular Medicine Signal Transduction Therapy for Cancer - Whither Now?
Current Signal Transduction Therapy Recent Advance in Isoform-Specific Regulation of Adenylyl Cyclase
Current Enzyme Inhibition Synthesis Techniques, Properties and Applications of Polymer Nanocomposites
Current Organic Synthesis Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Effects of Natural Products on Contact Dermatitis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Phytoestrogens: Implications in Neurovascular Research
Current Neurovascular Research GPCR Drug Discovery: Novel Ligands for CNS Receptors
Recent Patents on CNS Drug Discovery (Discontinued) New Approaches for the Synthesis of Heterocyclic Compounds Corporating Benzo[d]imidazole as Anticancer Agents, Tyrosine, Pim-1 Kinases Inhibitions and their PAINS Evaluations
Anti-Cancer Agents in Medicinal Chemistry